MPTP-induced Parkinsonism is associated with damage to Leydig cells and testosterone loss

Riccardo Ruffoli, Maria Anita Giambelluca, Maria Concetta Scavuzzo, Livia Pasquali, Francesco Giannessi, Francesco Fornai

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Genital dysfunction and testosterone deficiency occur frequently in Parkinson's disease and represent a typical non-motor symptom of the disorder. Despite that, to our knowledge no study investigated whether at experimental level this can be reproduced with classic Parkinsonism-inducing neurotoxins. In this study we evaluated the effects produced in the testis following administration of the Parkinsonism-inducing neurotoxin 1-methyl, 4-phenyl, 1,2,3,6-tetrahydropyridine in mice. At 7days following treatment, in the presence of a severe nigrostriatal dopamine depletion, we found a marked decrease in testosterone plasma levels in 1-methyl, 4-phenyl, 1,2,3,6-tetrahydropyridine-treated mice. Such testosterone loss occurred concomitantly with loss of Leydig cells and the presence of altered morphology in the interstitium with severe mitochondrial degeneration in spared Leydig cells. The loss of Leydig cells was accompanied by a marked decrease in TH immunohistochemistry and TH protein in the interstitium. This was accompanied by a significant decrease in norepinephrine levels in the testis. These effects shed novel light to understand genital dysfunction and testosterone deficiency in Parkinsonism, while offering a new experimental model to reproduce genital dysfunction in Parkinson's disease.

Original languageEnglish
Pages (from-to)218-223
Number of pages6
JournalBrain Research
Volume1229
DOIs
Publication statusPublished - Sep 10 2008

Fingerprint

MPTP Poisoning
Leydig Cells
Testosterone
Parkinsonian Disorders
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Neurotoxins
Parkinson Disease
Testis
Dopamine
Norepinephrine
Theoretical Models
Immunohistochemistry
Proteins

Keywords

  • Genital dysfunction
  • Leydig cells
  • MPTP
  • Norepinephrine
  • Parkinson's disease
  • Testosterone deficiency

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Neurology
  • Developmental Biology
  • Molecular Biology

Cite this

MPTP-induced Parkinsonism is associated with damage to Leydig cells and testosterone loss. / Ruffoli, Riccardo; Giambelluca, Maria Anita; Scavuzzo, Maria Concetta; Pasquali, Livia; Giannessi, Francesco; Fornai, Francesco.

In: Brain Research, Vol. 1229, 10.09.2008, p. 218-223.

Research output: Contribution to journalArticle

Ruffoli, Riccardo ; Giambelluca, Maria Anita ; Scavuzzo, Maria Concetta ; Pasquali, Livia ; Giannessi, Francesco ; Fornai, Francesco. / MPTP-induced Parkinsonism is associated with damage to Leydig cells and testosterone loss. In: Brain Research. 2008 ; Vol. 1229. pp. 218-223.
@article{143e20fd36de4f06a609de9cda51d6e2,
title = "MPTP-induced Parkinsonism is associated with damage to Leydig cells and testosterone loss",
abstract = "Genital dysfunction and testosterone deficiency occur frequently in Parkinson's disease and represent a typical non-motor symptom of the disorder. Despite that, to our knowledge no study investigated whether at experimental level this can be reproduced with classic Parkinsonism-inducing neurotoxins. In this study we evaluated the effects produced in the testis following administration of the Parkinsonism-inducing neurotoxin 1-methyl, 4-phenyl, 1,2,3,6-tetrahydropyridine in mice. At 7days following treatment, in the presence of a severe nigrostriatal dopamine depletion, we found a marked decrease in testosterone plasma levels in 1-methyl, 4-phenyl, 1,2,3,6-tetrahydropyridine-treated mice. Such testosterone loss occurred concomitantly with loss of Leydig cells and the presence of altered morphology in the interstitium with severe mitochondrial degeneration in spared Leydig cells. The loss of Leydig cells was accompanied by a marked decrease in TH immunohistochemistry and TH protein in the interstitium. This was accompanied by a significant decrease in norepinephrine levels in the testis. These effects shed novel light to understand genital dysfunction and testosterone deficiency in Parkinsonism, while offering a new experimental model to reproduce genital dysfunction in Parkinson's disease.",
keywords = "Genital dysfunction, Leydig cells, MPTP, Norepinephrine, Parkinson's disease, Testosterone deficiency",
author = "Riccardo Ruffoli and Giambelluca, {Maria Anita} and Scavuzzo, {Maria Concetta} and Livia Pasquali and Francesco Giannessi and Francesco Fornai",
year = "2008",
month = "9",
day = "10",
doi = "10.1016/j.brainres.2008.06.116",
language = "English",
volume = "1229",
pages = "218--223",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",

}

TY - JOUR

T1 - MPTP-induced Parkinsonism is associated with damage to Leydig cells and testosterone loss

AU - Ruffoli, Riccardo

AU - Giambelluca, Maria Anita

AU - Scavuzzo, Maria Concetta

AU - Pasquali, Livia

AU - Giannessi, Francesco

AU - Fornai, Francesco

PY - 2008/9/10

Y1 - 2008/9/10

N2 - Genital dysfunction and testosterone deficiency occur frequently in Parkinson's disease and represent a typical non-motor symptom of the disorder. Despite that, to our knowledge no study investigated whether at experimental level this can be reproduced with classic Parkinsonism-inducing neurotoxins. In this study we evaluated the effects produced in the testis following administration of the Parkinsonism-inducing neurotoxin 1-methyl, 4-phenyl, 1,2,3,6-tetrahydropyridine in mice. At 7days following treatment, in the presence of a severe nigrostriatal dopamine depletion, we found a marked decrease in testosterone plasma levels in 1-methyl, 4-phenyl, 1,2,3,6-tetrahydropyridine-treated mice. Such testosterone loss occurred concomitantly with loss of Leydig cells and the presence of altered morphology in the interstitium with severe mitochondrial degeneration in spared Leydig cells. The loss of Leydig cells was accompanied by a marked decrease in TH immunohistochemistry and TH protein in the interstitium. This was accompanied by a significant decrease in norepinephrine levels in the testis. These effects shed novel light to understand genital dysfunction and testosterone deficiency in Parkinsonism, while offering a new experimental model to reproduce genital dysfunction in Parkinson's disease.

AB - Genital dysfunction and testosterone deficiency occur frequently in Parkinson's disease and represent a typical non-motor symptom of the disorder. Despite that, to our knowledge no study investigated whether at experimental level this can be reproduced with classic Parkinsonism-inducing neurotoxins. In this study we evaluated the effects produced in the testis following administration of the Parkinsonism-inducing neurotoxin 1-methyl, 4-phenyl, 1,2,3,6-tetrahydropyridine in mice. At 7days following treatment, in the presence of a severe nigrostriatal dopamine depletion, we found a marked decrease in testosterone plasma levels in 1-methyl, 4-phenyl, 1,2,3,6-tetrahydropyridine-treated mice. Such testosterone loss occurred concomitantly with loss of Leydig cells and the presence of altered morphology in the interstitium with severe mitochondrial degeneration in spared Leydig cells. The loss of Leydig cells was accompanied by a marked decrease in TH immunohistochemistry and TH protein in the interstitium. This was accompanied by a significant decrease in norepinephrine levels in the testis. These effects shed novel light to understand genital dysfunction and testosterone deficiency in Parkinsonism, while offering a new experimental model to reproduce genital dysfunction in Parkinson's disease.

KW - Genital dysfunction

KW - Leydig cells

KW - MPTP

KW - Norepinephrine

KW - Parkinson's disease

KW - Testosterone deficiency

UR - http://www.scopus.com/inward/record.url?scp=49849095574&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=49849095574&partnerID=8YFLogxK

U2 - 10.1016/j.brainres.2008.06.116

DO - 10.1016/j.brainres.2008.06.116

M3 - Article

VL - 1229

SP - 218

EP - 223

JO - Brain Research

JF - Brain Research

SN - 0006-8993

ER -